{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T10:42:14Z","timestamp":1789987334483,"version":"4.0.1"},"reference-count":127,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2023,3,26]],"date-time":"2023-03-26T00:00:00Z","timestamp":1679788800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute (NCI)","doi-asserted-by":"publisher","award":["R01CA230744"],"award-info":[{"award-number":["R01CA230744"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>PTHrP exerts its effects by binding to its receptor, PTH1R, a G protein-coupled receptor (GPCR), activating the downstream cAMP signaling pathway. As an autocrine, paracrine, or intracrine factor, PTHrP has been found to stimulate cancer cell proliferation, inhibit apoptosis, and promote tumor-induced osteolysis of bone. Despite these findings, attempts to develop PTHrP and PTH1R as drug targets have not produced successful results in the clinic. Nevertheless, the efficacy of blocking PTHrP and PTH1R has been shown in various types of cancer, suggesting its potential for therapeutic applications. In light of these conflicting data, we conducted a comprehensive review of the studies of PTHrP\/PTH1R in cancer progression and metastasis and highlighted the strengths and limitations of targeting PTHrP or PTH1R in cancer therapy. This review also offers our perspectives for future research in this field.<\/jats:p>","DOI":"10.3390\/cancers15071982","type":"journal-article","created":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T02:18:27Z","timestamp":1679883507000},"page":"1982","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Parathyroid Hormone-Related Protein\/Parathyroid Hormone Receptor 1 Signaling in Cancer and Metastasis"],"prefix":"10.3390","volume":"15","author":[{"given":"Yawei","family":"Zhao","sequence":"first","affiliation":[{"name":"Department of Cell and Cancer Biology, College of Medicine and Life Sciences, The University of Toledo, Toledo, OH 43614, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0228-5380","authenticated-orcid":false,"given":"Shang","family":"Su","sequence":"additional","affiliation":[{"name":"Department of Cell and Cancer Biology, College of Medicine and Life Sciences, The University of Toledo, Toledo, OH 43614, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5074-193X","authenticated-orcid":false,"given":"Xiaohong","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Cell and Cancer Biology, College of Medicine and Life Sciences, The University of Toledo, Toledo, OH 43614, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,3,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1093\/clinchem\/38.11.2171","article-title":"Parathyroid hormone-related protein: Structure, function, and measurement","volume":"38","author":"Burtis","year":"1992","journal-title":"Clin. Chem."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/sj.bjp.0704378","article-title":"Parathyroid hormone-related protein and its receptors: Nuclear functions and roles in the renal and cardiovascular systems, the placental trophoblasts and the pancreatic islets","volume":"134","author":"Clemens","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"ref_3","first-page":"510","article-title":"Physiological roles of parathyroid hormone-related protein","volume":"90","author":"Lai","year":"2019","journal-title":"Acta Biomed."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s10911-013-9283-7","article-title":"Parathyroid hormone-related protein specifies the mammary mesenchyme and regulates embryonic mammary development","volume":"18","author":"Hiremath","year":"2013","journal-title":"J. Mammary Gland. Biol. Neoplasia"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1210\/jc.2012-2142","article-title":"Parathyroid hormone-related protein: An update","volume":"97","author":"Wysolmerski","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1101\/gad.8.3.277","article-title":"Lethal skeletal dysplasia from targeted disruption of the parathyroid hormone-related peptide gene","volume":"8","author":"Karaplis","year":"1994","journal-title":"Genes Dev."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1006\/dbio.1996.0104","article-title":"Haploinsufficiency of parathyroid hormone-related peptide (PTHrP) results in abnormal postnatal bone development","volume":"175","author":"Amizuka","year":"1996","journal-title":"Dev. Biol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1172\/JCI100218","article-title":"Studies of calcium and phosphorus metabolism: IV. The effect of the parathyroid hormone","volume":"7","author":"Albright","year":"1929","journal-title":"J. Clin. Investig."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1210\/endo.141.5.7470","article-title":"Enhanced growth of MCF-7 breast cancer cells overexpressing parathyroid hormone-related peptide","volume":"141","author":"Falzon","year":"2000","journal-title":"Endocrinology"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/bjc.1995.282","article-title":"Parathyroid hormone (PTH)\/PTH-related protein (PTHrP) receptor expression and mitogenic responses in human breast cancer cell lines","volume":"72","author":"Birch","year":"1995","journal-title":"Br. J. Cancer"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1158\/0008-5472.CAN-05-2814","article-title":"Parathyroid hormone-related protein localization in breast cancers predict improved prognosis","volume":"66","author":"Henderson","year":"2006","journal-title":"Cancer Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/jnci\/93.3.234","article-title":"Parathyroid hormone-related protein production by breast cancers, improved survival, and reduced bone metastases","volume":"93","author":"Henderson","year":"2001","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_13","first-page":"3817","article-title":"Humanized monoclonal antibody against parathyroid hormone-related protein suppresses osteolytic bone metastasis of human breast cancer cells derived from MDA-MB-231","volume":"25","author":"Saito","year":"2005","journal-title":"Anticancer. Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1172\/JCI118947","article-title":"Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis","volume":"98","author":"Guise","year":"1996","journal-title":"J. Clin. Investig."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/ijc.11586","article-title":"Parathyroid hormone-related protein (PTHrP) is responsible for production of bone metastasis, but not visceral metastasis, by human small cell lung cancer SBC-5 cells in natural killer cell-depleted SCID mice","volume":"108","author":"Miki","year":"2004","journal-title":"Int. J. Cancer"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1002\/jbmr.5650080711","article-title":"Passive immunization with anti-parathyroid hormone-related protein monoclonal antibody markedly prolongs survival time of hypercalcemic nude mice bearing transplanted human PTHrP-producing tumors","volume":"8","author":"Sato","year":"1993","journal-title":"J. Bone Miner. Res."},{"key":"ref_17","first-page":"2665","article-title":"Generation of a humanized monoclonal antibody against human parathyroid hormone-related protein and its efficacy against humoral hypercalcemia of malignancy","volume":"24","author":"Onuma","year":"2004","journal-title":"Anticancer Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"4655","DOI":"10.1172\/JCI46134","article-title":"PTHrP drives breast tumor initiation, progression, and metastasis in mice and is a potential therapy target","volume":"121","author":"Li","year":"2011","journal-title":"J. Clin. Investig."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Mak, I.W.Y., Cowan, R.W., Turcotte, R.E., Singh, G., and Ghert, M. (2011). PTHrP induces autocrine\/paracrine proliferation of bone tumor cells through inhibition of apoptosis. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0019975"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"6574","DOI":"10.1158\/0008-5472.CAN-12-4692","article-title":"Parathyroid hormone-related protein drives a CD11b+Gr1+ cell-mediated positive feedback loop to support prostate cancer growth","volume":"73","author":"Park","year":"2013","journal-title":"Cancer Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1158\/2159-8290.CD-20-1098","article-title":"PTHrP Drives Pancreatic Cancer Growth and Metastasis and Reveals a New Therapeutic Vulnerability","volume":"11","author":"Pitarresi","year":"2021","journal-title":"Cancer Discov."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/carcin\/bgi203","article-title":"Antitumor effect of parathyroid hormone-related protein neutralizing antibody in human renal cell carcinoma in vitro and in vivo","volume":"27","author":"Talon","year":"2006","journal-title":"Carcinogenesis"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1158\/0008-5472.CAN-03-1968","article-title":"Parathyroid hormone-related protein is an essential growth factor for human clear cell renal carcinoma and a target for the von Hippel-Lindau tumor suppressor gene","volume":"64","author":"Massfelder","year":"2004","journal-title":"Cancer Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41574-020-00426-5","article-title":"Emerging insights into the comparative effectiveness of anabolic therapies for osteoporosis","volume":"17","author":"Estell","year":"2021","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"13733","DOI":"10.1074\/jbc.M110.200196","article-title":"G alpha(q) signal in osteoblasts is inhibitory to the osteoanabolic action of parathyroid hormone","volume":"286","author":"Ogata","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1002\/jbmr.415","article-title":"A 7-day continuous infusion of PTH or PTHrP suppresses bone formation and uncouples bone turnover","volume":"26","author":"Horwitz","year":"2011","journal-title":"J. Bone Miner. Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1073\/pnas.0707457105","article-title":"Osteoblast expression of an engineered Gs-coupled receptor dramatically increases bone mass","volume":"105","author":"Hsiao","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1359\/JBMR.050602","article-title":"Continuous PTH and PTHrP infusion causes suppression of bone formation and discordant effects on 1,25(OH)2 vitamin D","volume":"20","author":"Horwitz","year":"2005","journal-title":"J. Bone Miner. Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.tem.2004.01.006","article-title":"Parathyroid hormone: A double-edged sword for bone metabolism","volume":"15","author":"Qin","year":"2004","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Kontogeorgos, G., Krantz, E., Trimpou, P., Laine, C.M., and Landin-Wilhelmsen, K. (2022). Teriparatide treatment in severe osteoporosis\u2014A controlled 10-year follow-up study. BMC Musculoskelet. Disord., 23.","DOI":"10.1186\/s12891-022-05987-2"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/j.1742-7843.2004.pto940602.x","article-title":"Teriparatide (biosynthetic human parathyroid hormone 1-34): A new paradigm in the treatment of osteoporosis","volume":"94","author":"Brixen","year":"2004","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1359\/jbmr.2003.18.1.9","article-title":"The effect of teriparatide human parathyroid hormone (1-34) therapy on bone density in men with osteoporosis","volume":"18","author":"Orwoll","year":"2003","journal-title":"J. Bone Miner. Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1359\/jbmr.2003.18.1.18","article-title":"The skeletal response to teriparatide is largely independent of age, initial bone mineral density, and prevalent vertebral fractures in postmenopausal women with osteoporosis","volume":"18","author":"Marcus","year":"2003","journal-title":"J. Bone Miner. Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","article-title":"Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis","volume":"344","author":"Neer","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1126\/science.aav7942","article-title":"Structure and dynamics of the active human parathyroid hormone receptor-1","volume":"364","author":"Zhao","year":"2019","journal-title":"Science"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.tem.2019.07.011","article-title":"PTH\/PTHrP Receptor Signaling, Allostery, and Structures","volume":"30","author":"Sutkeviciute","year":"2019","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/s41589-021-00929-w","article-title":"Precise druggability of the PTH type 1 receptor","volume":"18","author":"Sutkeviciute","year":"2022","journal-title":"Nat. Chem. Biol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"13384","DOI":"10.1038\/ncomms13384","article-title":"Identification of an orally active small-molecule PTHR1 agonist for the treatment of hypoparathyroidism","volume":"7","author":"Tamura","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1210\/me.2014-1129","article-title":"Actions of the small molecule ligands SW106 and AH-3960 on the type-1 parathyroid hormone receptor","volume":"29","author":"Carter","year":"2015","journal-title":"Mol. Endocrinol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"4789","DOI":"10.1021\/jm0707626","article-title":"Discovery and characterization of novel, potent, non-peptide parathyroid hormone-1 receptor antagonists","volume":"50","author":"McDonald","year":"2007","journal-title":"J. Med. Chem."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"6846","DOI":"10.1073\/pnas.0605125104","article-title":"Discovery of a small molecule antagonist of the parathyroid hormone receptor by using an N-terminal parathyroid hormone peptide probe","volume":"104","author":"Carter","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1124\/mol.117.111062","article-title":"G Protein-Coupled Receptors as Targets for Approved Drugs: How Many Targets and How Many Drugs?","volume":"93","author":"Sriram","year":"2018","journal-title":"Mol. Pharmacol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"16525","DOI":"10.1073\/pnas.0808750105","article-title":"Prolonged signaling at the parathyroid hormone receptor by peptide ligands targeted to a specific receptor conformation","volume":"105","author":"Okazaki","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1210\/me.2005-0349","article-title":"Mechanisms of ligand binding to the parathyroid hormone (PTH)\/PTH-related protein receptor: Selectivity of a modified PTH(1-15) radioligand for GalphaS-coupled receptor conformations","volume":"20","author":"Dean","year":"2006","journal-title":"Mol. Endocrinol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1074\/jbc.M408270200","article-title":"Novel parathyroid hormone (PTH) antagonists that bind to the juxtamembrane portion of the PTH\/PTH-related protein receptor","volume":"280","author":"Shimizu","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"49003","DOI":"10.1074\/jbc.M106827200","article-title":"Parathyroid hormone (PTH)-(1-14) and -(1-11) analogs conformationally constrained by alpha-aminoisobutyric acid mediate full agonist responses via the juxtamembrane region of the PTH-1 receptor","volume":"276","author":"Shimizu","year":"2001","journal-title":"J. Biol. Chem."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"689","DOI":"10.2174\/1381612013397825","article-title":"Molecular mechanisms of ligand recognition by parathyroid hormone 1 (PTH1) and PTH2 receptors","volume":"7","author":"Hoare","year":"2001","journal-title":"Curr. Pharm. Des."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.cmet.2015.11.003","article-title":"PTH\/PTHrP Receptor Mediates Cachexia in Models of Kidney Failure and Cancer","volume":"23","author":"Kir","year":"2016","journal-title":"Cell Metab."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"e90874","DOI":"10.1172\/jci.insight.90874","article-title":"Prevention of breast cancer skeletal metastases with parathyroid hormone","volume":"2","author":"Swami","year":"2017","journal-title":"JCI Insight"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"14078","DOI":"10.1074\/jbc.270.23.14078","article-title":"Cell type-specific secretion of parathyroid hormone-related protein via the regulated versus the constitutive secretory pathway","volume":"270","author":"Plawner","year":"1995","journal-title":"J. Biol. Chem."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Frieling, J.S., and Lynch, C.C. (2019). Proteolytic Regulation of Parathyroid Hormone-Related Protein: Functional Implications for Skeletal Malignancy. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20112814"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1124\/pr.114.009464","article-title":"International Union of Basic and Clinical Pharmacology. XCIII. The parathyroid hormone receptors\u2014Family B G protein-coupled receptors","volume":"67","author":"Gardella","year":"2015","journal-title":"Pharmacol. Rev."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0083-6729(03)01010-0","article-title":"Parathyroid hormone-related protein (PTHrP): A nucleocytoplasmic shuttling protein with distinct paracrine and intracrine roles","volume":"66","author":"Jans","year":"2003","journal-title":"Vitam. Horm."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"13630","DOI":"10.1073\/pnas.94.25.13630","article-title":"Opposing mitogenic and anti-mitogenic actions of parathyroid hormone-related protein in vascular smooth muscle cells: A critical role for nuclear targeting","volume":"94","author":"Massfelder","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/(SICI)1097-4644(19980801)70:2<193::AID-JCB5>3.0.CO;2-J","article-title":"The nucleus: A target site for parathyroid hormone-related peptide (PTHrP) action","volume":"70","author":"Nguyen","year":"1998","journal-title":"J. Cell. Biochem."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"4064","DOI":"10.1128\/MCB.15.8.4064","article-title":"Nucleolar localization of parathyroid hormone-related peptide enhances survival of chondrocytes under conditions that promote apoptotic cell death","volume":"15","author":"Henderson","year":"1995","journal-title":"Mol. Cell. Biol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"37934","DOI":"10.1074\/jbc.M105510200","article-title":"Parathyroid hormone-related protein promotes quiescence and survival of serum-deprived chondrocytes by inhibiting rRNA synthesis","volume":"276","author":"Aarts","year":"2001","journal-title":"J. Biol. Chem."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1210\/endo.138.3.4990","article-title":"Parathyroid hormone-related protein-(107-139) inhibits bone resorption in vivo","volume":"138","author":"Cornish","year":"1997","journal-title":"Endocrinology"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0014-5793(02)03164-2","article-title":"The COOH-terminus of parathyroid hormone-related protein (PTHrP) interacts with beta-arrestin 1B","volume":"527","author":"Conlan","year":"2002","journal-title":"FEBS Lett."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"e2122037119","DOI":"10.1073\/pnas.2122037119","article-title":"Functional modulation of PTH1R activation and signaling by RAMP2","volume":"119","author":"Nemec","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Chatterjee, M., and Kashfi, K. (2012). Cell Signaling & Molecular Targets in Cancer, Springer.","DOI":"10.1007\/978-1-4614-0730-0"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S1043-2760(01)00409-X","article-title":"Molecular properties of the PTH\/PTHrP receptor","volume":"12","author":"Gardella","year":"2001","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"10856","DOI":"10.1074\/jbc.M513380200","article-title":"Distinct beta-arrestin- and G protein-dependent pathways for parathyroid hormone receptor-stimulated ERK1\/2 activation","volume":"281","author":"Chen","year":"2006","journal-title":"J. Biol. Chem."},{"key":"ref_64","first-page":"1ra1","article-title":"A beta-arrestin-biased agonist of the parathyroid hormone receptor (PTH1R) promotes bone formation independent of G protein activation","volume":"1","author":"Flannery","year":"2009","journal-title":"Sci. Transl. Med."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1038\/s41467-023-36797-2","article-title":"Structural details of a Class B GPCR-arrestin complex revealed by genetically encoded crosslinkers in living cells","volume":"14","author":"Aydin","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/s41467-017-02661-3","article-title":"Lack of beta-arrestin signaling in the absence of active G proteins","volume":"9","author":"Grundmann","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"26469","DOI":"10.1074\/jbc.271.43.26469","article-title":"Full activation of chimeric receptors by hybrids between parathyroid hormone and calcitonin. Evidence for a common pattern of ligand-receptor interaction","volume":"271","author":"Bergwitz","year":"1996","journal-title":"J. Biol. Chem."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"16084","DOI":"10.1073\/pnas.0503942102","article-title":"Turn-on switch in parathyroid hormone receptor by a two-step parathyroid hormone binding mechanism","volume":"102","author":"Castro","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"19456","DOI":"10.1074\/jbc.M001596200","article-title":"Autoactivation of type-1 parathyroid hormone receptors containing a tethered ligand","volume":"275","author":"Shimizu","year":"2000","journal-title":"J. Biol. Chem."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1210\/endo.139.1.5679","article-title":"Angiotensin II-induced nuclear targeting of the angiotensin type 1 (AT1) receptor in brain neurons","volume":"139","author":"Lu","year":"1998","journal-title":"Endocrinology"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"15719","DOI":"10.1074\/jbc.274.22.15719","article-title":"Localization of functional prostaglandin E2 receptors EP3 and EP4 in the nuclear envelope","volume":"274","author":"Bhattacharya","year":"1999","journal-title":"J. Biol. Chem."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"7901","DOI":"10.1074\/jbc.M306377200","article-title":"Agonist-independent nuclear localization of the Apelin, angiotensin AT1, and bradykinin B2 receptors","volume":"279","author":"Lee","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"30469","DOI":"10.1074\/jbc.M501775200","article-title":"Functional metabotropic glutamate receptors on nuclei from brain and primary cultured striatal neurons. Role of transporters in delivering ligand","volume":"280","author":"Jong","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_74","first-page":"254","article-title":"New insights into mechanisms of nuclear translocation of G-protein coupled receptors","volume":"10","author":"Bhosle","year":"2019","journal-title":"Small GTPases"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1359\/jbmr.2000.15.6.1033","article-title":"Nuclear localization of the type 1 PTH\/PTHrP receptor in rat tissues","volume":"15","author":"Watson","year":"2000","journal-title":"J. Bone Miner. Res."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1210\/en.2007-0157","article-title":"Type 1 parathyroid hormone receptor (PTH1R) nuclear trafficking: Regulation of PTH1R nuclear-cytoplasmic shuttling by importin-alpha\/beta and chromosomal region maintenance 1\/exportin 1","volume":"148","author":"Pickard","year":"2007","journal-title":"Endocrinology"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1074\/jbc.270.1.151","article-title":"The cytoplasmic tail of the G-protein-coupled receptor for parathyroid hormone and parathyroid hormone-related protein contains positive and negative signals for endocytosis","volume":"270","author":"Huang","year":"1995","journal-title":"J. Biol. Chem."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.bone.2007.04.201","article-title":"Expression of PTH1R constructs in LLC-PK1 cells: Protein nuclear targeting is mediated by the PTH1R NLS","volume":"41","author":"Patterson","year":"2007","journal-title":"Bone"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.1210\/en.2005-1408","article-title":"Type 1 parathyroid hormone receptor (PTH1R) nuclear trafficking: Association of PTH1R with importin alpha1 and beta","volume":"147","author":"Pickard","year":"2006","journal-title":"Endocrinology"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"11281","DOI":"10.1074\/jbc.M413393200","article-title":"Parathyroid hormone receptor trafficking contributes to the activation of extracellular signal-regulated kinases but is not required for regulation of cAMP signaling","volume":"280","author":"Syme","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"588773","DOI":"10.3389\/fendo.2020.588773","article-title":"The Efficacy of PTH and Abaloparatide to Counteract Immobilization-Induced Osteopenia Is in General Similar","volume":"11","author":"Brent","year":"2020","journal-title":"Front. Endocrinol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1210\/me.2007-0274","article-title":"Altered selectivity of parathyroid hormone (PTH) and PTH-related protein (PTHrP) for distinct conformations of the PTH\/PTHrP receptor","volume":"22","author":"Dean","year":"2008","journal-title":"Mol. Endocrinol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/nchembio.545","article-title":"Retromer terminates the generation of cAMP by internalized PTH receptors","volume":"7","author":"Feinstein","year":"2011","journal-title":"Nat. Chem. Biol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/nchembio.1589","article-title":"Endosomal GPCR signaling turned off by negative feedback actions of PKA and v-ATPase","volume":"10","author":"Gidon","year":"2014","journal-title":"Nat. Chem. Biol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/s41568-020-0263-0","article-title":"The dormant cancer cell life cycle","volume":"20","author":"Phan","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.bbrc.2004.11.162","article-title":"Direct evidence that PTHrP expression promotes prostate cancer progression in bone","volume":"327","author":"Deftos","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/ijc.22749","article-title":"Over-expression of parathyroid hormone Type 1 receptor confers an aggressive phenotype in osteosarcoma","volume":"121","author":"Yang","year":"2007","journal-title":"Int. J. Cancer"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/(SICI)1097-4652(199601)166:1<94::AID-JCP11>3.0.CO;2-P","article-title":"Expression of parathyroid hormone-related protein in cells of osteoblast lineage","volume":"166","author":"Suda","year":"1996","journal-title":"J. Cell. Physiol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1677\/joe.0.1220219","article-title":"Production of parathyroid hormone-like peptide in a human osteosarcoma cell line: Stimulation by phorbol esters and epidermal growth factor","volume":"122","author":"Rodan","year":"1989","journal-title":"J. Endocrinol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1038\/onc.2014.217","article-title":"Knockdown of PTHR1 in osteosarcoma cells decreases invasion and growth and increases tumor differentiation in vivo","volume":"34","author":"Ho","year":"2015","journal-title":"Oncogene"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.bone.2013.02.016","article-title":"Modeling distinct osteosarcoma subtypes in vivo using Cre:lox and lineage-restricted transgenic shRNA","volume":"55","author":"Mutsaers","year":"2013","journal-title":"Bone"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1101\/gad.1656808","article-title":"Conditional mouse osteosarcoma, dependent on p53 loss and potentiated by loss of Rb, mimics the human disease","volume":"22","author":"Walkley","year":"2008","journal-title":"Genes Dev."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/s41419-018-0944-8","article-title":"Tolerance to sustained activation of the cAMP\/Creb pathway activity in osteoblastic cells is enabled by loss of p53","volume":"9","author":"Walia","year":"2018","journal-title":"Cell Death Dis."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"e13446","DOI":"10.7554\/eLife.13446","article-title":"Activation of PTHrP-cAMP-CREB1 signaling following p53 loss is essential for osteosarcoma initiation and maintenance","volume":"5","author":"Walia","year":"2016","journal-title":"eLife"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/onc.2014.41","article-title":"PKA signaling drives mammary tumorigenesis through Src","volume":"34","author":"Beristain","year":"2015","journal-title":"Oncogene"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.canlet.2021.10.042","article-title":"Enzalutamide-induced and PTH1R-mediated TGFBR2 degradation in osteoblasts confers resistance in prostate cancer bone metastases","volume":"525","author":"Su","year":"2022","journal-title":"Cancer Lett."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1038\/nm753","article-title":"Parathyroid hormone-related peptide is a naturally occurring, protein kinase A-dependent angiogenesis inhibitor","volume":"8","author":"Bakre","year":"2002","journal-title":"Nat. Med."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.mce.2019.01.005","article-title":"PTHrP treatment of colon cancer cells promotes tumor associated-angiogenesis by the effect of VEGF","volume":"483","author":"Calvo","year":"2019","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_99","first-page":"2755","article-title":"PTHrP regulates angiogenesis and bone resorption via VEGF expression","volume":"30","author":"Isowa","year":"2010","journal-title":"Anticancer Res."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"4313","DOI":"10.1210\/endo.141.11.7875","article-title":"Parathyroid hormone-related peptide is a potent tumor angiogenic factor","volume":"141","author":"Akino","year":"2000","journal-title":"Endocrinology"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/ng.1049","article-title":"Genome-wide association analysis identifies three new breast cancer susceptibility loci","volume":"44","author":"Ghoussaini","year":"2012","journal-title":"Nat. Genet."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"6355","DOI":"10.1158\/1078-0432.CCR-17-3280","article-title":"Loss of Nuclear Localized Parathyroid Hormone-Related Protein in Primary Breast Cancer Predicts Poor Clinical Outcome and Correlates with Suppressed Stat5 Signaling","volume":"24","author":"Tran","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/sj.bjc.6600115","article-title":"Parathyroid hormone related peptide and receptor expression in paired primary prostate cancer and bone metastases","volume":"86","author":"Bryden","year":"2002","journal-title":"Br. J. Cancer"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1378\/chest.09-1358","article-title":"Parathyroid hormone-related peptide and parathyroid hormone-related peptide receptor type 1 expression in human lung adenocarcinoma","volume":"137","author":"Monego","year":"2010","journal-title":"Chest"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"R130","DOI":"10.1186\/bcr3328","article-title":"Low levels of Stat5a protein in breast cancer are associated with tumor progression and unfavorable clinical outcomes","volume":"14","author":"Peck","year":"2012","journal-title":"Breast Cancer Res."},{"key":"ref_106","unstructured":"Peck, A.R., Witkiewicz, A.K., Liu, C., Stringer, G.A., Klimowicz, A.C., Pequignot, E., Freydin, B., Tran, T.H., Yang, N., and Rosenberg, A.L. (2011). Clinical Research, 2011\/04\/15, American Association for Cancer Research."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"pkz063","DOI":"10.1093\/jncics\/pkz063","article-title":"PTHrP, A Biomarker for CNS Metastasis in Triple-Negative Breast Cancer and Selection for Adjuvant Chemotherapy in Node-Negative Disease","volume":"4","author":"Assaker","year":"2020","journal-title":"JNCI Cancer Spectr."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.cllc.2011.03.018","article-title":"Prognostic implications of parathyroid hormone-related protein in males and females with non\u2014Small-cell lung cancer","volume":"12","author":"Montgrain","year":"2011","journal-title":"Clin. Lung Cancer"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1002\/(SICI)1097-0142(19990915)86:6<1028::AID-CNCR19>3.0.CO;2-G","article-title":"Parathyroid hormone-related protein is an independent prognostic factor for renal cell carcinoma","volume":"86","author":"Iwamura","year":"1999","journal-title":"Cancer"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"e10126","DOI":"10.1002\/jbm4.10126","article-title":"Bone as a Preferential Site for Metastasis","volume":"3","author":"Sowder","year":"2019","journal-title":"JBMR Plus"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1158\/1535-7163.MCT-07-0234","article-title":"Molecular biology of bone metastasis","volume":"6","author":"Kingsley","year":"2007","journal-title":"Mol. Cancer Ther."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/BF02967463","article-title":"Significance of the parathyroid hormone-related protein expression in breast carcinoma","volume":"7","author":"Yoshida","year":"2000","journal-title":"Breast Cancer"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0031-3025(16)36341-3","article-title":"Immunohistochemical localization of parathyroid hormone-related protein in the lesions of breast disease","volume":"22","author":"Southby","year":"1990","journal-title":"Pathology"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1007\/s10585-014-9682-1","article-title":"Wnt signaling induces gene expression of factors associated with bone destruction in lung and breast cancer","volume":"31","author":"Johnson","year":"2014","journal-title":"Clin. Exp. Metastasis"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1158\/0008-5472.CAN-10-2993","article-title":"TGF-beta promotion of Gli2-induced expression of parathyroid hormone-related protein, an important osteolytic factor in bone metastasis, is independent of canonical Hedgehog signaling","volume":"71","author":"Johnson","year":"2011","journal-title":"Cancer Res."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"7548","DOI":"10.1158\/0008-5472.CAN-06-0452","article-title":"The hedgehog signaling molecule Gli2 induces parathyroid hormone-related peptide expression and osteolysis in metastatic human breast cancer cells","volume":"66","author":"Sterling","year":"2006","journal-title":"Cancer Res."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1056\/NEJMoa1113713","article-title":"Efficacy and safety of vismodegib in advanced basal-cell carcinoma","volume":"366","author":"Sekulic","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1200\/JCO.2013.49.9525","article-title":"Open-label, exploratory phase II trial of oral itraconazole for the treatment of basal cell carcinoma","volume":"32","author":"Kim","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/sj.bjc.6603828","article-title":"Inhibition of epidermal growth factor receptor signalling reduces hypercalcaemia induced by human lung squamous-cell carcinoma in athymic mice","volume":"97","author":"Lorch","year":"2007","journal-title":"Br. J. Cancer"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s10585-011-9398-4","article-title":"Erlotinib inhibits osteolytic bone invasion of human non-small-cell lung cancer cell line NCI-H292","volume":"28","author":"Furugaki","year":"2011","journal-title":"Clin. Exp. Metastasis"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/ncb3408","article-title":"Induction of LIFR confers a dormancy phenotype in breast cancer cells disseminated to the bone marrow","volume":"18","author":"Johnson","year":"2016","journal-title":"Nat. Cell Biol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"e2214396119","DOI":"10.1073\/pnas.2214396119","article-title":"Structure-based design of selective, orally available salt-inducible kinase inhibitors that stimulate bone formation in mice","volume":"119","author":"Sato","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_123","doi-asserted-by":"crossref","unstructured":"Zhao, L.-H., Yuan, Q., Dai, A., Chen, C.-W., He, X., Zhang, C., Xu, Y., Zhou, Y., Wang, M.-W., and Yang, D. (2022). Molecular recognition of two endogenous hormones by the human parathyroid hormone receptor-1. Acta Pharmacol. Sin.","DOI":"10.1038\/s41401-022-01032-z"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"3468","DOI":"10.1016\/j.molcel.2022.07.003","article-title":"Endogenous ligand recognition and structural transition of a human PTH receptor","volume":"82","author":"Kobayashi","year":"2022","journal-title":"Mol. Cell"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1016\/j.crfs.2022.10.031","article-title":"Advances in the stability challenges of bioactive peptides and improvement strategies","volume":"5","author":"Pei","year":"2022","journal-title":"Curr. Res. Food Sci."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1021\/acsptsci.2c00142","article-title":"Proteolysis Targeting Chimeras (PROTACs): A Perspective on Integral Membrane Protein Degradation","volume":"5","author":"Ruffilli","year":"2022","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"928794","DOI":"10.3389\/fphar.2022.928794","article-title":"The Role of Membrane-Associated E3 Ubiquitin Ligases in Cancer","volume":"13","author":"Chen","year":"2022","journal-title":"Front. Pharmacol."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/15\/7\/1982\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:03:31Z","timestamp":1760123011000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/15\/7\/1982"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,26]]},"references-count":127,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2023,4]]}},"alternative-id":["cancers15071982"],"URL":"https:\/\/doi.org\/10.3390\/cancers15071982","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,26]]}}}